quetiapine SR

DRUG4 trials

Sponsors

AstraZeneca, University of South Florida, The University of Texas Health Science Center at San Antonio

Conditions

Anxiety DisordersBipolar DisorderGeneralized Anxiety DisorderMajor Depressive DisorderPanic Disorder

Phase 3

Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.

CompletedNCT00314210

AstraZenecaAnxiety Disorders

Start: 2006-03-31End: 2007-08-31Target: 575Updated: 2009-03-25

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder

CompletedNCT00351169

AstraZenecaMajor Depressive Disorder

Start: 2006-05-31End: 2007-06-30Target: 450Updated: 2008-12-22

Phase 4

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD

CompletedNCT00579280

University of South FloridaBipolar Disorder, Generalized Anxiety Disorder, Panic Disorder

Start: 2007-07-31End: 2010-12-31Updated: 2020-06-11

Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder

CompletedNCT01195363

The University of Texas Health Science Center at San AntonioBipolar Disorder

Start: 2007-04-30End: 2011-06-30Updated: 2017-03-23